Skip to main content
Fig. 7 | Journal of Experimental & Clinical Cancer Research

Fig. 7

From: Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

Fig. 7

The relationship between Maspin staining and survival rate in MIBC patients receiving NACT plus RC-PLND. a and b showed Kaplan-Meier survival curves of the OS and PFS in the 62 patients, respectively. The results indicated Maspin expression was related to OS and PFS (P = 0.0036 and 0.0005, respectively)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us